Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 13,508 $ 17,777 $ 29,752 $ 36,023
General and administrative 7,455 8,999 15,078 16,711
Restructuring and impairment costs 37,196 0 39,779 0
Total operating expenses 58,159 26,776 84,609 52,734
Loss from operations (58,159) (26,776) (84,609) (52,734)
Other income (expense), net:        
Interest income, net 2,845 840 5,432 963
Loss on disposal of assets 0 0 (71) 0
Total other income, net 2,845 840 5,361 963
Net loss (55,314) (25,936) (79,248) (51,771)
Unrealized gain (loss) on investments in marketable securities 198 (724) 777 (1,033)
Comprehensive loss $ (55,116) $ (26,660) $ (78,471) $ (52,804)
Net loss per share attributable to common stockholders-basic $ (0.97) $ (0.48) $ (1.4) $ (0.95)
Net loss per share attributable to common stockholders-diluted $ (0.97) $ (0.48) $ (1.4) $ (0.95)
Weighted-average shares used in computing net loss per share-basic 56,745,347 54,572,866 56,499,160 54,284,836
Weighted-average shares used in computing net loss per share-diluted 56,745,347 54,572,866 56,499,160 54,284,836